Harley-Davidson (HOG) Q3 Earnings and Revenues Top Estimates (Revised)
LivaNova PLC LIVN was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 20.4% in the past one-month time frame.
The move came after the company reported better-than-expected second-quarter 2018 results.
The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
LivaNova currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
LivaNova PLC Price
LivaNova PLC Price | LivaNova PLC Quote
Investors interested in the Medical - Instruments industry may consider Inogen, Inc. INGN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is LIVN going up? Or down? Predict to see what others think:Up or Down
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inogen, Inc (INGN) : Free Stock Analysis Report
LivaNova PLC (LIVN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research